NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Osanni Bio

Osanni Bio

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://osanni.bio/

Last Round

Series B

Jun 23, 2026

Total Funding Raised

$217M

Momentum

Top 1%

of companies Caplight tracks

Company Overview

Osanni Bio is a biotechnology company that operates a development-stage therapeutics platform to discover and develop new medicines, with programs in ophthalmology, cardiology, and oncology.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Revenue Share

AI Layer

Application

Keywords

drug discoverydrug developmenthub-and-spoke modelasset-centric biotechbiotech venture creationtherapeutics platformophthalmology therapeuticsage-related macular degenerationcardiology therapeuticsoncology therapeuticsproof-of-concept developmentcapital-efficient drug developmentAI-augmented drug discoveryretinal image analysis

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Osanni Bio Comps

Public and private peers based on sector, stage, and business model.

Osanni Bio comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Osanni Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BJun 23, 2026
SeedOct 1, 2022

Key People

Founding team and executive leadership

D. Michael Ackermann

Chief Executive Officer

Executive Team

Osanni Bio Investors

Notable investors and investment history

Osanni Bio investors
InvestorRounds
Horowitz GroupSeries A, Seed, Series B
Patient Square CapitalSeries B
Invus OpportunitiesSeries A, Seed, Series B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 23, 2026

    $190M round led by Patient Square Capital

  • Jan 17, 2025

    Grew 21% QoQ from 19 to 23 employees.

Osanni Bio Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Osanni Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Osanni Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range33
Year Founded2022
Last FundingJun 23, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.